Hospital-acquired pneumonia: Epidemiology, etiology, and treatment
Hospital-acquired pneumonia: Epidemiology, etiology, and treatment
复制标题
DOI：
10.1016/s0891-5520(05)70209-9
复制
发表时间：
1998-09-01
影响因子：
4.4
通讯作者：
Campbell, GD
中科院分区：
文献类型：
--
作者：
McEachern, R;Campbell, GD
尽管诊断、治疗和预防方面有所改进，但医院获得性肺炎（HAP）仍然是院内死亡的第一大原因。本文回顾了有关 HAP 的发病率、流行病学和病因的当前知识，认识到现有信息不完整且争议很常见，因此作者为免疫功能正常的成人中 HAP 的初始管理提供了合理的方法。其中包括对治疗的讨论以及如何处理对经验性治疗没有反应的患者。美国胸科学会 (ATS) 关于 HAP 的声明已成为本次综述的基础，但已通过 ATS 声明制定时未提供的新文献进行了补充。
Despite improvements in diagnosis, treatment, and prevention, hospital-acquired pneumonia (HAP) remains the number one cause of nosocomial mortality. This article reviews the current knowledge regarding the incidence, epidemiology, and causes of HAP, with the appreciation that the available information is incomplete and that controversies are common, and thus the authors provide a rational approach to the initial management of HAP in immunocompetent adults. A discussion of therapy and what to do with patients who do not respond to the empiric therapy are included. The American Thoracic Society (ATS) statement on HAP has served as a foundation for this review but has been supplemented by newer Literature that was not available when the ATS statement was developed.